摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,5-trimethyl-1H-pyrazole-4-sulfonic acid (3-fluoro-4-{6-methoxy-7-[3-morpholin-4-yl-propoxy]quinolin-4-yloxy}phenyl)amide | 1293291-81-2

中文名称
——
中文别名
——
英文名称
1,3,5-trimethyl-1H-pyrazole-4-sulfonic acid (3-fluoro-4-{6-methoxy-7-[3-morpholin-4-yl-propoxy]quinolin-4-yloxy}phenyl)amide
英文别名
N-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1,3,5-trimethylpyrazole-4-sulfonamide
1,3,5-trimethyl-1H-pyrazole-4-sulfonic acid (3-fluoro-4-{6-methoxy-7-[3-morpholin-4-yl-propoxy]quinolin-4-yloxy}phenyl)amide化学式
CAS
1293291-81-2
化学式
C29H34FN5O6S
mdl
——
分子量
599.683
InChiKey
YXZYBFVLBLCVHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    42
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    125
  • 氢给体数:
    1
  • 氢受体数:
    11

文献信息

  • [EN] QUINOLINYLOXYPHENYLSULFONAMIDES<br/>[FR] QUINOLINYLOXYPHÉNYLSULFONAMIDES
    申请人:MAX PLANCK GESELLSCHAFT
    公开号:WO2011045084A1
    公开(公告)日:2011-04-21
    The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.
    本发明涉及喹啉氧基苯磺酰胺及其立体异构体形式、溶剂化物、合物和/或这些喹啉氧基苯磺酰胺化合物的药学上可接受的盐,以及含有至少一种这些化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的制剂。所述喹啉氧基苯磺酰胺对于预防、治疗和/或后治疗增生性疾病,如癌症、肿瘤,特别是癌症转移,具有有用的作用。
  • QUINOLINYLOXYPHENYLSULFONAMIDES
    申请人:Ullrich Axel
    公开号:US20120277231A1
    公开(公告)日:2012-11-01
    The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.
    本发明涉及喹啉氧基苯磺酰胺及其立体异构体、溶剂化物、合物和/或药学上可接受的盐,以及至少包含其中一种化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的制药组合物。所述喹啉氧基苯磺酰胺对于预防、治疗和/或后治疗增生性疾病,如癌症、肿瘤和特别是癌症转移,具有有用的作用。
  • US9169241B2
    申请人:——
    公开号:US9169241B2
    公开(公告)日:2015-10-27
查看更多